Literature DB >> 20651226

Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death.

Ze-Hua Zhu1, Yan P Yu, Zhong-Liang Zheng, Yang Song, Guo-Sheng Xiang, Joel Nelson, George Michalopoulos, Jian-Hua Luo.   

Abstract

Integrins are a family of receptors for extracellular matrix proteins that have critical roles in human tissue development. Previous studies identified down-regulation and/or mutations of integrin alpha7 (ITGA7) in prostate cancer, liver cancer, soft tissue leiomyosarcoma, and glioblastoma multiforme. Here we report that expression of ITGA7 induced apoptosis in the human prostate cancer cell lines PC3 and DU145. Yeast two-hybrid analysis revealed that the C-terminus of ITGA7 interacts with high temperature requirement A2 (HtrA2), a serine protease with a critical role in apoptosis. Expression of ITGA7 increases the protease activity of HtrA2 both in vitro and in vivo. Deletion of the HtrA2 interaction domain abrogates the cell death activity of ITGA7, whereas down-regulation of HtrA2 dramatically reduced cell death mediated by ITGA7. In addition, site-directed protease-null mutant HtrA2S306A expression blocked apoptosis induced by ITGA7. Interestingly, interaction between ITGA7 and its ligand laminin 2 appears to protect against cell death, since depleting laminin beta2 with a small-interfering RNA significantly exacerbated apoptosis induced by ITGA7 expression. This report provides a novel insight into the mechanism by which ITGA7 acts as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651226      PMCID: PMC2928952          DOI: 10.2353/ajpath.2010.091026

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Impaired axonal regeneration in alpha7 integrin-deficient mice.

Authors:  A Werner; M Willem; L L Jones; G W Kreutzberg; U Mayer; G Raivich
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes.

Authors:  C Brakebusch; R Grose; F Quondamatteo; A Ramirez; J L Jorcano; A Pirro; M Svensson; R Herken; T Sasaki; R Timpl; S Werner; R Fässler
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.

Authors:  Lucia Cilenti; Younghee Lee; Sibylle Hess; Srinivasa Srinivasula; Kwon Moo Park; Daniela Junqueira; Hedvika Davis; Joseph V Bonventre; Emad S Alnemri; Antonis S Zervos
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

Review 4.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

5.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.

Authors:  J H Wijsman; R R Jonker; R Keijzer; C J van de Velde; C J Cornelisse; J H van Dierendonck
Journal:  J Histochem Cytochem       Date:  1993-01       Impact factor: 2.479

6.  Expression, purification, and functional analysis of the human serine protease HtrA2.

Authors:  J W Savopoulos; P S Carter; S Turconi; G R Pettman; E H Karran; C W Gray; R V Ward; O Jenkins; C L Creasy
Journal:  Protein Expr Purif       Date:  2000-07       Impact factor: 1.650

7.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.

Authors:  Y Suzuki; Y Imai; H Nakayama; K Takahashi; K Takio; R Takahashi
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

8.  A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3.

Authors:  R B Basani; D L French; G Vilaire; D L Brown; F Chen; B S Coller; J M Derrick; T K Gartner; J S Bennett; M Poncz
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.

Authors:  Anne M Verhagen; John Silke; Paul G Ekert; Miha Pakusch; Hitto Kaufmann; Lisa M Connolly; Catherine L Day; Anjali Tikoo; Richard Burke; Carolyn Wrobel; Robert L Moritz; Richard J Simpson; David L Vaux
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

10.  Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.

Authors:  Baoguo Ren; Yan P Yu; George C Tseng; Chuanyue Wu; Ka Chen; Uma N Rao; Joel Nelson; George K Michalopoulos; Jian-Hua Luo
Journal:  J Natl Cancer Inst       Date:  2007-06-06       Impact factor: 13.506

View more
  6 in total

1.  The DNA replication licensing factor miniature chromosome maintenance 7 is essential for RNA splicing of epidermal growth factor receptor, c-Met, and platelet-derived growth factor receptor.

Authors:  Zhang-Hui Chen; Yan P Yu; George Michalopoulos; Joel Nelson; Jian-Hua Luo
Journal:  J Biol Chem       Date:  2014-11-25       Impact factor: 5.157

2.  Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.

Authors:  Lang-Zhu Tan; Yang Song; Joel Nelson; Yan P Yu; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-07-02       Impact factor: 4.307

3.  Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model.

Authors:  Qiang Chen; Lei Chen; Ren Zhao; Xiao-dong Yang; Khan Imran; Chun-gen Xing
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-07       Impact factor: 4.553

4.  Integrin α7: a major driver and therapeutic target for glioblastoma malignancy.

Authors:  Andreia M Nunes; Pamela Barraza-Flores; Christina R Smith; Dean J Burkin
Journal:  Stem Cell Investig       Date:  2017-12-18

5.  Integrin α7 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma.

Authors:  Zhiyong Wu; Xiaoyu Kong; Zhihui Wang
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

6.  S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.

Authors:  Ya-Ling Hsu; Jen-Yu Hung; Yung-Yu Liang; Yi-Shiuan Lin; Ming-Ju Tsai; Shah-Hwa Chou; Chi-Yu Lu; Po-Lin Kuo
Journal:  Oncotarget       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.